ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 142 filers reported holding ENDOLOGIX INC in Q4 2016. The put-call ratio across all filers is 126.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $3,832,000 | -25.1% | 906,002 | -5.2% | 0.47% | -31.7% |
Q4 2017 | $5,115,000 | -23.2% | 956,002 | -36.0% | 0.69% | -18.7% |
Q3 2017 | $6,657,000 | -13.0% | 1,492,600 | -5.2% | 0.85% | -22.7% |
Q2 2017 | $7,655,000 | -33.9% | 1,575,000 | -1.6% | 1.10% | -40.1% |
Q1 2017 | $11,584,000 | +252.2% | 1,600,000 | +178.3% | 1.83% | +190.6% |
Q4 2016 | $3,289,000 | -99.9% | 575,000 | +32.2% | 0.63% | -28.6% |
Q3 2016 | $5,568,000,000 | +102630.6% | 435,000 | 0.0% | 0.88% | -8.1% |
Q2 2016 | $5,420,000 | +49.0% | 435,000 | 0.0% | 0.96% | +33.2% |
Q1 2016 | $3,637,000 | -12.5% | 435,000 | +3.6% | 0.72% | +14.8% |
Q4 2015 | $4,158,000 | +48.1% | 420,000 | +83.4% | 0.63% | +40.4% |
Q3 2015 | $2,808,000 | +2.3% | 229,000 | +27.9% | 0.45% | +35.8% |
Q2 2015 | $2,746,000 | -17.1% | 179,000 | -7.7% | 0.33% | -40.9% |
Q1 2015 | $3,312,000 | +11.7% | 194,000 | 0.0% | 0.56% | -35.1% |
Q4 2014 | $2,966,000 | +39.9% | 194,000 | -3.0% | 0.86% | +38.5% |
Q3 2014 | $2,120,000 | -32.0% | 200,000 | -2.4% | 0.62% | -32.9% |
Q2 2014 | $3,118,000 | +20.0% | 205,000 | +1.6% | 0.92% | +18.6% |
Q1 2014 | $2,598,000 | +83.9% | 201,843 | +149.1% | 0.78% | +41.0% |
Q4 2013 | $1,413,000 | – | 81,027 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|